infectious diseases, and other complex health challenges. The company engages in collaborative research with other biotechnology and pharmaceutical organizations to progress clinical-stage programs and expand its development pipeline.

Human Genome Sciences produces biologically derived molecules such as monoclonal antibodies and proteins intended for clinical testing, with some candidates progressing through advanced trials prior to regulatory review. Its work contributed to the development of therapies aimed at addressing diseases with unmet medical needs by leveraging gene-based discovery platforms and translational research approaches.